Literature DB >> 15034227

Family-based association study between the monoamine oxidase A gene and obesity: implications for psychopharmacogenetic studies.

Beatriz Camarena1, Haydee Santiago, Alejandro Aguilar, Elsa Ruvinskis, Jorge González-Barranco, Humberto Nicolini.   

Abstract

Family studies have reported that obesity has a strong heritable component. It has been suggested that a neurotransmitter dysfunction could be involved in mental disorders and obesity; therefore, candidate genes in psychiatric disorders could be a risk factor for obesity. We investigated the association between the monoamine oxidase A (MAO-A) gene and obesity. Fifty obese subjects and their parents were included in the study. Two polymorphisms designated EcoRV and upstream variable number tandem repeats of the MAO-A gene were analysed using polymerase chain reaction. For analysis of the families, the transmission disequilibrium test (TDT) was applied. The TDT analysis of the EcoRV polymorphism showed in obese subjects with a body mass index (BMI) >/=35 kg/m(2) a preferential transmission of the low activity-related allele (chi(2)(TDT) = 8.0, p = 0.005). Our findings may provide evidence of a candidate gene involved in obese subjects with a BMI >/=35 kg/m(2). Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034227     DOI: 10.1159/000076720

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  9 in total

1.  Change in the Binding of [11C]BU99008 to Imidazoline I2 Receptor Using Brain PET in Zucker Rats.

Authors:  Kazunori Kawamura; Tomoteru Yamasaki; Yiding Zhang; Hidekatsu Wakizaka; Akiko Hatori; Lin Xie; Masayuki Fujinaga; Ming-Rong Zhang
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

Review 2.  Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity.

Authors:  Ansley Grimes Stanfill; Yvette Conley; Ann Cashion; Carol Thompson; Ramin Homayouni; Patricia Cowan; Donna Hathaway
Journal:  Biol Res Nurs       Date:  2015-01-09       Impact factor: 2.522

3.  Genes implicated in serotonergic and dopaminergic functioning predict BMI categories.

Authors:  Bernard F Fuemmeler; Tanya D Agurs-Collins; F Joseph McClernon; Scott H Kollins; Melanie E Kail; Andrew W Bergen; Allison E Ashley-Koch
Journal:  Obesity (Silver Spring)       Date:  2008-02       Impact factor: 5.002

4.  Gender difference in interactions between MAOA promoter uVNTR polymorphism and negative familial stressors on body mass index among Chinese adolescents.

Authors:  B Xie; D Li; S J London; P H Palmer; C A Johnshon; Y Li; J Shih; A W Bergen; D Nishita; G E Swan; R Ahn; D V Conti
Journal:  Pediatr Obes       Date:  2013-06-13       Impact factor: 4.000

5.  Lipid levels are associated with a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR).

Authors:  Beverly H Brummett; Stephen H Boyle; Ilene C Siegler; Stephan Zuchner; Allison Ashley-Koch; Redford B Williams
Journal:  Med Sci Monit       Date:  2008-02

6.  Interactions between genotype and depressive symptoms on obesity.

Authors:  Bernard F Fuemmeler; Tanya Agurs-Collins; F Joseph McClernon; Scott H Kollins; Melanie E Garrett; Allison E Ashley-Koch
Journal:  Behav Genet       Date:  2009-04-01       Impact factor: 2.805

Review 7.  Do Dopaminergic Impairments Underlie Physical Inactivity in People with Obesity?

Authors:  Alexxai V Kravitz; Timothy J O'Neal; Danielle M Friend
Journal:  Front Hum Neurosci       Date:  2016-10-14       Impact factor: 3.169

8.  Are dopamine-related genotypes risk factors for excessive gestational weight gain?

Authors:  Gary S Goldfield; Lauren Marie Dowler; Mark Walker; Jameason D Cameron; Zachary M Ferraro; Eric Doucet; Kristi B Adamo
Journal:  Int J Womens Health       Date:  2013-05-20

9.  MAOA promoter methylation and susceptibility to carotid atherosclerosis: role of familial factors in a monozygotic twin sample.

Authors:  Jinying Zhao; Christopher W Forsberg; Jack Goldberg; Nicholas L Smith; Viola Vaccarino
Journal:  BMC Med Genet       Date:  2012-11-02       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.